IMMUNOGLOBULIN G1 (HUMAN-RAT MONOCLONAL CAMPATH-1H .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD52), DISULFIDE WITH HUMAN-RAT MONOCLONAL CAMPATH-1H LIGHT CHAIN, DIMER
Kidney Cancer
Baylor College of Medicinemonoclonal_antibodyN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 73/ 100
Competitive context
70 Active assets in the Kidney Cancer cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Alpha-Interferon Dartmouth-Hitchcock Medical Center | Phase 3 | BBB |
Girentuximab Memorial Sloan Kettering Cancer Center | Phase 3 | BB |
Girentuximab Heidelberg Pharma AG | Phase 3 | BB |
ETOPOSIDE City of Hope Medical Center | Phase 3 | BB |
FILGRASTIM National Institutes of Health Clinical Center (CC) | Phase 3 | BB |
View all 50 →
Same molecule, other indications
IMMUNOGLOBULIN G1 (HUMAN-RAT MONOCLONAL CAMPATH-1H .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD52), DISULFIDE WITH HUMAN-RAT MONOCLONAL CAMPATH-1H LIGHT CHAIN, DIMER is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →